Galmed Pharmaceuticals GLMD Q4 2025 Earnings Miss Sparks Concern Cocrystal COCP Declines 357 Amid Market Weakness 20260515 MFS Muni CMU Stalls at 348 Consolidation Phase 20260514 Huadi HUDI Gains 862 Support Holds at 120 20260515 Iran Reviews US Peace Proposal Trump Signals Willingness to Wait Potential Implications for Oil Markets SunCar Technology Warrant SDAWW Slides 17 as Key Support Holds at 006 Telecom TEO Q1 2026 Delivers Revenue 832881400000000 EPS 144378 Surges Banco Santander SAN Q1 2026 Earnings Strong EPS Surprise Offsets Slight Stock Dip Berkshire Hathaway Portfolio Reshuffle New Stakes in Delta Air Lines and Alphabet Indian Equity Indices Edge Higher Sensex Gains 230 Points Nifty 50 Closes Above 23700 as Banking Stocks Outperform Options Trading Without the BlackScholes Model The Case for ChartBased Strategies Nvidia Shares Dip 13 Despite 745 Billion Profit and 102 Billion Buyback SpaceX OpenAI and Anthropic May Surpass Berkshire Hathaways Market Value on Debut Polymarket Suggests Crude Oil Futures Maintain Upward Momentum Amid Supply Concerns WHLR Q2 2024 Earnings EPS of 365 Strengthens as Stock Declines 136 TaskUs Inc TASK Q1 2026 Earnings Small EPS Miss on Modest Revenue Uncertainty TEO Q1 2026 Earnings Massive EPS Surprise Driven by Exceptional Performance WIT Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Gain CDXS Q1 2026 Earnings Surprise EPS Beat Despite Revenue Uncertainty Mortgage and Refinance Interest Rates Decline on May 23 2026 Rates Fall Across Key Loan Types FEIM Q1 2026 Earnings EPS Falls Short of Expectations Yet Stock Surges Over 13 Nasdaq Inc NDAQ Q1 2026 Earnings Modest EPS Beat Amid Market Volatility EDRY Q1 2026 Earnings Significant EPS Miss Amid Challenging Dry Bulk Market ASX Q1 2026 Earnings EPS Surpasses Estimates by 9 Stock Rises AB Q1 2026 Earnings Earnings Miss Estimates Amid Market Headwinds Intrusion Inc INTZ Q1 2026 Earnings EPS Misses Estimates Sharply Shares Rise Amid Uncertainty Lesaka Technologies Q1 2026 Earnings EPS Surges Past Estimates with 978 Surprise ABUS Q1 2026 Earnings Wider Loss Than Expected as Biotech Reports No Revenue